Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Rheumatoid Arthritis Activity Using DAS28 in Patients Treated With Subcutaneously Administered Tocilizumab on Local Level

NCT02534311 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT02534311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02534311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Rheumatoid Arthritis Activity Using DAS28 in Patients Treated With Subcutaneously Administered Tocilizumab on Local Level
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
October 13, 2015
Completion date
December 1, 2015
Enrollment
60 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis